Reply

Affiliations

Comment

Darrell S Pardi et al. Clin Gastroenterol Hepatol. 2019 Feb.

. 2019 Feb;17(3):572.

doi: 10.1016/j.cgh.2018.08.074.

¹ Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

No abstract available

Comment on

Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.
Cotter TG, Gathaiya N, Catania J, Loftus EV Jr, Tremaine WJ, Baddour LM, Harmsen WS, Zinsmeister AR, Sandborn WJ, Limper AH, Pardi DS. Cotter TG, et al. Clin Gastroenterol Hepatol. 2017 Jun;15(6):850-856. doi: 10.1016/j.cgh.2016.11.037. Epub 2016 Dec 21. Clin Gastroenterol Hepatol. 2017. PMID: 28013116 Free PMC article.
Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.
Macaluso FS, Cottone M, Orlando A. Macaluso FS, et al. Clin Gastroenterol Hepatol. 2019 Feb;17(3):571-572. doi: 10.1016/j.cgh.2017.06.020. Epub 2017 Jun 15. Clin Gastroenterol Hepatol. 2019. PMID: 28625815 No abstract available.